Pentraxin 3, ischemia-modified albumin, and myeloperoxidase in predicting a cardiac damage in acute carbon monoxide poisoning

Baydın A., AMANVERMEZ R., Celebi H. E., Tunçel Ö. K., Demircan S.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.34, sa.10, ss.1927-1930, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 10
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.ajem.2016.05.043
  • Dergi Adı: AMERICAN JOURNAL OF EMERGENCY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1927-1930
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Background: Carbonmonoxide (CO) poisoning is associated with cardiac injuries or manifestations, frequently attributing to direct hypoxic damage at cellular level. For this, the aims were to evaluate the role of serum pentraxin 3 (PTX 3), ischemia-modified albumin (IMA), and myeloperoxidase (MPO) as an early biomarker for cardiac damage when compared to cardiac troponin I (cTnI) and creatine kinase-MB fraction (CK-MB) in adult patients with acute CO poisoning.